The partnership aims to advance pharmaceutical and life sciences ventures originating from BIRAD- Bar-Ilan University, turning laboratory discoveries into solutions that address unmet medical needs.
RAMAT GAN, Israel and NEW YORK, March 19, 2025 -- Arieli Group, a global investment firm, and BIRAD Research & Development Company Ltd., the technology transfer arm of Bar-Ilan University (BIU), have announced a partnership aimed at accelerating the commercialization of groundbreaking pharmaceutical and life sciences innovations developed by researchers at the University.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
